Characterization of clofazimine metabolites in humans by HPLC-electrospray mass spectrometry

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 3, 1997, Pages 303-306

  Krishna, Devarakonda R ^a   Mamidi, Rao N V S ^b   Hofmann, Ute ^c   Prabhakar, Chinnappa M ^a  

^a KAKATIYA UNIVERSITY   (India)

^b DR REDDY S RESEARCH FOUNDATION   (India)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

antileprotics; CAS 2030 63 9; clofazimine, clinical studies, metabolites

Indexed keywords

CLOFAZIMINE; DRUG METABOLITE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; THIN LAYER CHROMATOGRAPHY;

ADULT; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; CLOFAZIMINE; HUMANS; LEPROSTATIC AGENTS; LIVER; MALE; MASS SPECTROMETRY;

EID: 0030948065     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Yawalkar, S. J., Vischer, W. Lepr. Rev. 50, 135 (1979)
2. Levy, L., Am. J. Trop. Med. Hyg. 23, 1097 (1974)
3. Jopling, W. H., Lepr. Rev. 47, 1 (1976)
4. Banerjee, D. K., Ellard, G. A., Gammon, P. T. et al., Am. J. Trop. Med. Hyg. 23, 1110 (1974)
5. Browne, G., Hogerzeil, L. M., Lepr. Rev. 33, 6 (1962)
6. Browne, G., Hogenzeil, L. M., Lepr. Rev. 33, 6 (1962)
7. Feng, P. C. C., Fenselau, C. C., Jacobson, R. R., Drug Metab. Dispos. 9, 521 (1981)
8. Feng, P. C. C., Fenselau, C. C., Jacobson, R. R., Drug Metab. Dispos. 10, 286 (1982)